Feedback / Questions
varlitinib (ASLAN001) - ASLAN
http://globenewswire.com/news-release/2019/01/13/1690751/0/en/ASLAN-Pharmaceuticals-Announces-Study-Results-from-Phase-2-Study-of-Varlitinib-in-First-line-Gastric-Cancer.html
Jan 13, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next